Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05992363 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction

Study acronym: TSTENT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase: Phase 3 to Not applicablev2 Show 6 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Dec 2025 to Dec 2026
    • Study completion date: Dec 2026 to Dec 2027
    • Start date changed from estimate of Oct 2023 to Dec 20, 2023
    • Secondary endpoints revised (2)
    • Site details revised at 2 of 2 sites
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Malignant ureteral obstruction (MUO) is an extrinsic ureteral obstruction caused by malignant diseases. This study aim to compare tandem 6 Fr Percuflex™ stents and single large-caliber 8Fr silicone stent in patients with MUO. The primary endpoint is stent failure rate. The secondary endpoints are patient comfort, quality of life and overall survival.
Trial Details
NCT Number NCT05992363
Lead Sponsor Rabin Medical Center
Collaborators: Sheba Medical Center
Conditions
(from sponsor)		 Hydronephrosis; Obstruction, Ureter, Renal Failure, Malignancy, Ureter Obstruction, Ureter Stricture
Related terms Bites and Stings, Hydronephrosis, Neoplasms, Renal Insufficiency, Ureteral Obstruction
Enrollment 106 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov